Product approvals

FILE - This Thursday, June 30, 2011, file photo shows a sign in front of the Eli Lilly and Company corporate headquarters in Indianapolis. On Friday, April 14, 2017, Eli Lilly said U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November 2016. (AP Photo/Darron Cummings, File)
April 14, 2017 - 12:34 pm
Eli Lilly said U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November. The Food and Drug Administration said in a letter to the company that it needed more information about the drug's...
Read More
April 14, 2017 - 11:27 am
Eli Lilly says U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November. The Food and Drug Administration said in a letter to the company that additional data from patient tests would be...
Read More
This photo provided by Neurocrine Biosciences, Inc. shows the label on a bottle of the drug Ingrezza. On Tuesday, April 11, 2017, the Food and Drug Administration approved Ingrezza, the first drug for treating a neurological syndrome that causes uncontrollable body movements that can also interfere with speech, swallowing and breathing. (Neurocrine Biosciences, Inc. via AP)
April 11, 2017 - 6:10 pm
TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for treating a neurological syndrome that causes uncontrollable body movements that can also interfere with speech, swallowing and breathing. The sometimes-disabling disorder, tardive dyskinesia, is caused by some widely used...
Read More
In this March 29, 2017 photo, Joyce Endresen wears an Optune therapy device for brain cancer, as she speaks on a phone at work in Aurora, Ill. She was diagnosed in December 2014 with Glioblastoma. She had two surgeries to remove the tumor as well as radiation and chemotherapy, but is now trying the new therapy that requires her to wear the electrodes on her head as much as possible. They create low intensity electric fields that disrupt cell reproduction, which makes the cells die. (AP Photo/Carrie Antlfinger)
April 02, 2017 - 2:59 pm
WASHINGTON (AP) — It sounds like science fiction, but a cap-like device that makes electric fields to fight cancer improved survival for the first time in more than a decade for people with deadly brain tumors, final results of a large study suggest. Many doctors are skeptical of the therapy,...
Read More
In this March 29, 2017 photo, Joyce Endresen wears an Optune therapy device for brain cancer, as she speaks on a phone at work in Aurora, Ill. She was diagnosed in December 2014 with Glioblastoma. She had two surgeries to remove the tumor as well as radiation and chemotherapy, but is now trying the new therapy that requires her to wear the electrodes on her head as much as possible. They create low intensity electric fields that disrupt cell reproduction, which makes the cells die. (AP Photo/Carrie Antlfinger)
April 02, 2017 - 11:55 am
WASHINGTON (AP) — It sounds like science fiction, but a cap-like device that makes electric fields to fight cancer improved survival for the first time in more than a decade for people with deadly brain tumors, final results of a large study suggest. Many doctors are skeptical of the therapy,...
Read More
In this March 29, 2017 photo, Joyce Endresen wears an Optune therapy device for brain cancer, as she speaks on a phone at work in Aurora, Ill. She was diagnosed in December 2014 with Glioblastoma. She had two surgeries to remove the tumor as well as radiation and chemotherapy, but is now trying the new therapy that requires her to wear the electrodes on her head as much as possible. They create low intensity electric fields that disrupt cell reproduction, which makes the cells die. (AP Photo/Carrie Antlfinger)
April 02, 2017 - 11:51 am
WASHINGTON (AP) — It sounds like science fiction, but a cap-like device that makes electric fields to fight cancer improved survival for the first time in more than a decade for people with deadly brain tumors, final results of a large study suggest. Many doctors are skeptical of the therapy,...
Read More
Veronica Fuertes embraces her daughter Violeta Penalba, who suffers epilepsy, and is treated with marijuana, as they stand outside the Senate in Buenos Aires, Argentina, Wednesday, March 29, 2017. The Senate is expected to vote into law the medicinal use of marijuana on Wednesday. (AP Photo/Natacha Pisarenko)
March 29, 2017 - 10:09 pm
BUENOS AIRES, Argentina (AP) — Argentina's Senate has given final legislative approval to a bill legalizing the use of cannabis oil and other marijuana derivatives for medicinal purposes, and setting up a regulatory framework for the state to prescribe and distribute them to patients. The...
Read More
This image provided by Sanofi shows a box containing two single-dose pre-filled syringes of the drug Dupixent. On Tuesday, March 28, 2017, the Food and Drug Administration approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs. (Rodrigo Cid/Sanofi via AP)
March 28, 2017 - 1:58 pm
TRENTON, N.J. (AP) — U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and...
Read More
March 28, 2017 - 12:25 pm
TRENTON, N.J. (AP) — U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and...
Read More
March 21, 2017 - 5:05 pm
U.S. regulators have approved the first new drug in a decade for Parkinson's disease, a neurological disorder that causes tremors and movement difficulties. The Food and Drug Administration says it has approved Xadago (Zah-DAH'-goh) for use when a patient's regular medicines aren't working well...
Read More

Pages